Clinical Trial Update: Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing iron isomaltoside/ferric derisomaltose to iron sucrose for iron deficiency anemia in non-dialysis-dependent chronic kidney disease; comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Iron isomaltoside/ferric derisomaltose (ferric derisomaltose)
• Iron sucrose (iron sucrose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2020-03-06